World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects-Reference-Cited by-同舟云学术

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

Published:2012-12-06 Issue:1 Volume:14 Page:2-44
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Hasan Alkomiet,Falkai Peter,Wobrock Thomas,Lieberman Jeffrey,Glenthoj Birte,Gattaz Wagner F.,Thibaut Florence,Möller Hans-Jürgen,

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.3109/15622975.2012.739708

Reference321 articles.

1. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

2. Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial

3. Harmonizing the Metabolic Syndrome

Cited by 350 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Monitoring for Adults Living with a Serious Mental Illness on a Second-Generation Antipsychotic Agent: A Scoping Review;Administration and Policy in Mental Health and Mental Health Services Research;2024-08-17

2. Constipation‐associated factors in outpatients with schizophrenia: A multicenter questionnaire survey;Neuropsychopharmacology Reports;2024-07-03

3. Comparing the Perspectives of Generative AI, Mental Health Experts, and the General Public on Schizophrenia Recovery: Case Vignette Study;JMIR Mental Health;2024-03-18

4. Clinical Experience on the Use of a Single-day, Two-injection Start Initiation Regimen of Aripiprazole Once Monthly in Patients With Schizophrenia in Spain: SaTISfy Study;Journal of Psychiatric Practice;2024-03

5. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE) project;Psychiatry Research Communications;2024-03